Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.7 0 (0%) Market Cap: 2.45 Bil Enterprise Value: 4.93 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

Amneal Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2021 / 05:15PM GMT
Release Date Price: €4.12 (-2.83%)
Arek Kurkciyan

Good afternoon, everyone, and thank you for joining us at Morgan Stanley's Healthcare Conference this year. My name is Arek Kurkciyan. I'm with Morgan Stanley's Healthcare Investment Banking Group. And before we kick off, I'd like to read the following disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

And with that, I'd like to welcome the folks here at Amneal Pharmaceuticals. We have a number of the management team with us here. I'm joined by Chirag and Chintu Patel, who are co-founders and co-CEOs of Amneal as well as Tasos Konidaris, who is Chief Financial Officer. Gentlemen, thank you for joining us this afternoon.

Chirag K. Patel;Chintu Patel
Amneal Pharmaceuticals, Inc. - Co-Founder, Co-CEO, President & Director;

Thank you, Arek.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot